SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-079997
Filing Date
2022-03-21
Accepted
2022-03-21 06:30:57
Documents
13
Period of Report
2022-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d285779d8ka.htm   iXBRL 8-K/A 35343
2 EX-99.1 d285779dex991.htm EX-99.1 126914
  Complete submission text file 0001193125-22-079997.txt   333861

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adgi-20220223.xsd EX-101.SCH 2513
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adgi-20220223_lab.xml EX-101.LAB 19523
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adgi-20220223_pre.xml EX-101.PRE 12214
7 EXTRACTED XBRL INSTANCE DOCUMENT d285779d8ka_htm.xml XML 4293
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40703 | Film No.: 22754170
SIC: 2836 Biological Products, (No Diagnostic Substances)